Pretreatment frequency of circulating IL‐17+CD4+ T‐cells, but not Tregs, correlates with clinical response to whole‐cell vaccination in prostate cancer patients

Overview of attention for article published in International Journal of Cancer, July 2009

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

policy: 1 policy source

patent: 1 patent

Readers on

mendeley: 53 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 1 patent that references this research output.

BIOMARKER FOR PREDICTING RESPONSE TO CANCER TREATMENT

Application WO-2022054796-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.